Potential new targets in arthritis therapy: interleukin (IL)‐17 and its relation to tumour necrosis factor and IL‐1 in experimental arthritis

per Koenders, M I, Joosten, L A B, van den Berg, W B
Publicat 2006

HDAC inhibitors modulate innate immune responses to micro‐organisms relevant to chronic mucocutaneous candidiasis

per Rösler, B., Wang, X., Keating, S. T., Joosten, L. A. B., Netea, M. G., van de Veerdonk, F. L.
Publicat a Clin Exp Immunol (2018)

GM‐CSF neutralisation suppresses inflammation and protects cartilage in acute streptococcal cell wall arthritis of mice

per Plater‐Zyberk, C, Joosten, L A B, Helsen, M M A, Hepp, J, Baeuerle, P A, van den Berg, W B
Publicat 2007

Romidepsin suppresses monosodium urate crystal-induced cytokine production through upregulation of suppressor of cytokine signaling 1 expression

per Cleophas, M. C. P., Crişan, T. O., Klück, V., Hoogerbrugge, N., Netea-Maier, R. T., Dinarello, C. A., Netea, M. G., Joosten, L. A. B.
Publicat a Arthritis Res Ther (2019)

Validation of cellular tests for Lyme borreliosis (VICTORY) study

per van de Schoor, F. R., Baarsma, M. E., Gauw, S. A., Joosten, L. A. B., Kullberg, B. J., van den Wijngaard, C. C., Hovius, J. W.
Publicat a BMC Infect Dis (2019)

Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw

per Lubberts, E, Joosten, L A B, Van Den Bersselaar, L, Helsen, M M A, Bakker, A C, Xing, Z, Richards, C D, Van Den Berg, W B
Publicat 2000

Milder clinical hyperimmunoglobulin E syndrome phenotype is associated with partial interleukin-17 deficiency

per van de Veerdonk, F L, Marijnissen, R, Joosten, L A B, Kullberg, B J, Drenth, J P H, Netea, M G, van der Meer, J W M
Publicat 2010

Defective trained immunity in patients with STAT-1-dependent chronic mucocutaneaous candidiasis

per Ifrim, D C, Quintin, J, Meerstein-Kessel, L, Plantinga, T S, Joosten, L A B, van der Meer, J W M, van de Veerdonk, F L, Netea, M G
Publicat a Clin Exp Immunol (2015)

Risk of infections in patients with gout: a population-based cohort study

per Spaetgens, B., de Vries, F., Driessen, J. H. M., Leufkens, H. G., Souverein, P. C., Boonen, A., van der Meer, J. W. M., Joosten, L. A. B.
Publicat a Sci Rep (2017)

Mimicking Behçet’s disease: GM‐CSF gain of function mutation in a family suffering from a Behçet’s disease‐like disorder marked by extreme pathergy

per Rösler, B., Heinhuis, B., Wang, X., Silvestre, R., Joosten, L. A. B., Netea, M. G., Arts, P., Mantere, T., Lefeber, D. J., Hoischen, A., van de Veerdonk, F. L.
Publicat a Clin Exp Immunol (2021)

Association of a variable number tandem repeat in the NLRP3 gene in women with susceptibility to RVVC

per Jaeger, M., Carvalho, A., Cunha, C., Plantinga, T. S., van de Veerdonk, F., Puccetti, M., Galosi, C., Joosten, L. A. B., Dupont, B., Kullberg, B. J., Sobel, J. D., Romani, L., Netea, M. G.
Publicat a Eur J Clin Microbiol Infect Dis (2016)

Aspergillus Cell Wall Chitin Induces Anti- and Proinflammatory Cytokines in Human PBMCs via the Fc-γ Receptor/Syk/PI3K Pathway

per Becker, K. L., Aimanianda, V., Wang, X., Gresnigt, M. S., Ammerdorffer, A., Jacobs, C. W., Gazendam, R. P., Joosten, L. A. B., Netea, M. G., Latgé, J. P., van de Veerdonk, F. L.
Publicat a mBio (2016)

Different Patterns of Toll-Like Receptor 2 Polymorphisms in Populations of Various Ethnic and Geographic Origins

per Ioana, M., Ferwerda, B., Plantinga, T. S., Stappers, M., Oosting, M., McCall, M., Cimpoeru, A., Burada, F., Panduru, N., Sauerwein, R., Doumbo, O., van der Meer, J. W. M., van Crevel, R., Joosten, L. A. B., Netea, M. G.
Publicat 2012

Urate-induced epigenetic modifications in myeloid cells

per Badii, M., Gaal, O. I., Cleophas, M. C., Klück, V., Davar, R., Habibi, E., Keating, S. T., Novakovic, B., Helsen, M. M., Dalbeth, N., Stamp, L. K., Macartney-Coxson, D., Phipps-Green, A. J., Stunnenberg, H. G., Dinarello, C. A., Merriman, T. R., Netea, M. G., Crişan, T. O., Joosten, L. A. B.
Publicat a Arthritis Res Ther (2021)

Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

per van Bon, L., Affandi, A.J., Broen, J., Christmann, R.B., Marijnissen, R.J., Stawski, L., Farina, G.A., Stifano, G., Mathes, A.L., Cossu, M., York, M., Collins, C., Wenink, M., Huijbens, R., Hesselstrand, R., Saxne, T., DiMarzio, M., Wuttge, D., Agarwal, S.K., Reveille, J.D., Assassi, S., Mayes, M., Deng, Y., Drenth, J.P.H., de Graaf, J., den Heijer, M., Kallenberg, C.G.M., Bijl, M., Loof, A., van den Berg, W.B., Joosten, L.A.B., Smith, V., de Keyser, F., Scorza, R., Lunardi, C., van Riel, P.L.C.M., Vonk, M., van Heerde, W., Meller, S., Homey, B., Beretta, L., Roest, M., Trojanowska, M., Lafyatis, R., Radstake, T.R.D.J.
Publicat 2013